Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012

About the Associate Director


Barbara A. Conley, M.D., is Associate Director of the Cancer Diagnosis Program (CDP) in the Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute. She is also a member of the Division’s Experimental Therapeutics Clinic. Her previous positions at the Institute included Chief of the CDP Diagnostics Research Branch, Senior Investigator in the Cancer Therapy and Evaluation Program Clinical Investigations Branch, and Head, Aerodigestive Diseases in the intramural Medicine Branch. More…


The Cancer Diagnosis Program (CDP) strives to improve patient outcomes by effectively moving molecular diagnostics into clinical practice. The program stimulates, coordinates, and funds resources and research on diagnostics and improvements in technologies to better characterize cancers to develop information that can aid cancer patients and their physicians in clinical decision making.

CDP supports research at medical centers, hospitals, businesses, and universities throughout the United States, Canada, and other countries.

CDP is divided into three branches:

  • Diagnostic Biomarkers and Technology Branch
  • Resources Development Branch
  • Diagnostics Evaluation Branch

CDP, often in cooperation with other programs of the National Cancer Institute (NCI), offers a range of initiatives that encourage and support research in cancer diagnostics and related development of technology and specimen resources.

CDP administered 183 funded grants in 2009.